ADMA Biologics makes immune globulin treatments from human blood plasma for patients with weakened immune systems. It last closed at $13.63 on Nov 17, up 1.19% on the day. In the past 30 days there were 1 dark pool print totaling $1.6M, the largest $1.6M.
Only 1 firm rated ADMA in the past 90 days, not enough for a consensus
Average 12-month target
$13.00
▼ 4.6% downside
Based on 1 analyst who set a price target on ADMA in the past 90 days. The average target is $13.00, with a high of $13.00 and a low of $13.00, compared with the last close of $13.63.
Low $13.00Avg $13.00High $13.00
Blue marker: last close $13.63
Highest target$13.00
Average target$13.00
Lowest target$13.00
Latest rating changes
Cantor FitzgeraldMaintained
Nov 5Hold$13
MizuhoMaintained
Jul 15Buy$17
Canaccord GenuityInitiated
Apr 21Buy$21
Date
Firm
Action
Rating
Price target
Nov 5
Cantor Fitzgerald
Maintained
Hold
$13
Jul 15
Mizuho
Maintained
Buy
$17
Apr 21
Canaccord Genuity
Initiated
Buy
$21
Loading…
Technical Analysis
ADMA · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 12% above its 20 day and 21% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 69), near overbought. The nearest support is the Pivot at $13.47, and the nearest resistance the Pivot R1 at $13.81.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 4.6%/day
Key levels
$20.4652 week high+50.1%
$13.81Pivot R1+1.3%
$13.63Last close
$13.47Pivot−1.2%
$13.28Pivot S1−2.6%
$12.0320 day average−11.7%
$10.7350 day average−21.3%
$10.69200 day average−21.6%
$10.57Swing low (Oct 23)−22.5%
$9.95100 day average−27.0%
$7.2152 week low−47.1%
Indicators
RSI (14)
69.13
Strong, overbought above 70
Neutral
MACD
0.82
Above its signal line
Bullish
Stochastic
88.0
Near the top of its range
Overbought
ADX (14)
35.2
Trending up
Williams %R
-11.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
96.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+22.7%
Change over 10 sessions
Bullish
ATR (14)
$0.63
Typical daily range, 4.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchOverbought
VolatilityNormal, 8.4%/day
Key levels
$20.4652 week high+50.1%
$13.81Pivot R1+1.3%
$13.63Last close
$13.47Pivot−1.2%
$13.28Pivot S1−2.6%
$12.0320 day average−11.7%
$10.7350 day average−21.3%
$10.69200 day average−21.6%
$10.57Swing low (Oct 23)−22.5%
$9.95100 day average−27.0%
$7.2152 week low−47.1%
Indicators
RSI (14)
70.32
Overbought above 70
Overbought
MACD
0.50
Above its signal line
Bullish
Stochastic
90.9
Near the top of its range
Overbought
ADX (14)
27.3
Trending up
Williams %R
-7.6
Oversold below −80, overbought above −20
Overbought
CCI (20)
207.4
Oversold below −100, overbought above 100
Overbought
Rate of change
+47.7%
Change over 10 sessions
Bullish
ATR (14)
$1.14
Typical daily range, 8.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200–
What happened before, for ADMA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ADMA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ADMA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ADMA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADMA is in one of them and how their past ADMA trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Adma Biologics
ADMA Biologics is a biopharmaceutical company based in Ramsey, New Jersey. It makes specialty biologics from human blood plasma for people with weakened immune systems and for people at risk of certain infectious diseases. Its main products are ASCENIV and BIVIGAM, two immune globulin treatments for primary immunodeficiency, and Nabi-HB, which is used after exposure to hepatitis B. The company also operates plasma collection centers, sells some plasma to other manufacturers, and its products are mainly used by physician specialists.